Variants Distribution And Heterogeneity Of Outcomes To Crizotinib In Alk-Rearranged Chinese Non-Small Cell Lung Cancers

N. Liang, P. Xing,Y. Su,X. Long,Y. Gao,P. Chen,Z. Zhang,J. Liu,B. Li,T. Zhang,X. Mao,L. Zhang,H. Liu

JOURNAL OF THORACIC ONCOLOGY（2018）

Cited 0|Views2

No score

Abstract

subgroup, and gender (P1⁄40.007) was independent prognostic factor for OS in the EGFR mutation subgroup. Conclusion: This study confirmed the importance of pretreatment GNRI in predicting the OS in geriatric patients with metastatic lung adenocarcinoma, especially in the patients not harboring EGFR mutations.

Translated text

Key words

non-small cell lung cancers,ALK,Crizotinib

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined